Re: Please, Lord
 

Penny,

I pray for you every day.

Love and blessings,
Amy

Re: Please, Lord
 

Penny,
Thinking of you and sending prayers.
Cindy

Re: Please, Lord
 

Penny, Wondering how you are doing??? Please let us know.
Still praying for you.

Re: Please, Lord
 

Hey, Penny, another with Keytruda! I've seen this drug in action! This one is in AZ. Best of luck.
Love Karen


NEW Keytruda with Herceptin or Kadcyla in Advanced Breast (and Other) Cancer
A Phase Ib/II Study of Pembrolizumab and Monoclonal Antibody Therapy in Patients With Advanced Cancer (PembroMab (NCT02318901)

Summary
Pembrolizumab (Keytruda®) is a new immunotherapy agent that works by blocking a protein called programmed cell death (PD-1) that normally keeps the body's immune system from attacking and destroying tumor cells. It has recently approved for treating metastatic melanoma and may also be effective in other types of cancer. Ado-trastuzumab ematansine/T-DM1 (Kadcyla®) is a HER2-targeted therapy that combines the chemotherapy drug DMI with the HER2-targeted therapy trastuzumab (Herceptin®). In patients with HER2+ metastatic breast cancer, this study will compare the safety and effectiveness of Keytruda and Herceptin with Keytruda and Kadcyla. Patients with other types of cancers will be enrolled in different arms of the study.
This is a Phase I-II trial